Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands

Authors

  • Weder Pereira Cardoso Heliópolis Hospital
  • Odilon Victor Porto Denardin Heliópolis Hospital
  • Abrão Rapoport Heliópolis Hospital
  • Vera Cavalcanti Araújo Universidade de São Paulo
  • Marcos Brasilino Carvalho Heliópolis Hospital

Keywords:

Proliferating cell nuclear antigen, Mucoepidermoid Carcinoma, Salivary Gland

Abstract

CONTEXT: Among the cytological and morphological properties of mucoepidermoid carcinoma, one of the most important criteria for measuring its biological behavior and aggressiveness is cell proliferation. In this way, immunohistochemical markers of cell proliferation have been found to be useful in tumor classification and have formed part of the prognostic and therapeutic studies of these pathologies. OBJECTIVE: To analyze 11 cases of mucoepidermoid carcinoma (MEC) using the proliferation activity marker (PCNA) and to determine its relationship to the grade of malignancy of these tumors. DESIGN: Correlation study. SETTING: Head and Neck Surgery Service of Heliópolis Hospital, São Paulo, Brazil. SAMPLE: Slides of 11 cases of primary mucoepidermoid carcinomas of salivary glands were prepared according to routine techniques employed in the Oral Pathology Department of the Dentistry Faculty of São Paulo University, Brazil. They were fixed in a 10% formaldehyde solution and stained with hematoxylin and eosin. After this preparation the tumors were classified as low, intermediate and high grade of malignancy, according to the criteria established by Seifert & Sobin and Auclair, Goode & Ellis. The slides were sent for immunohistochemical processing to evaluate the positivity of proliferating cell nuclear antigen using the streptavidin biotin technique. MAIN MEASUREMENT: The correlation between proliferating cell nuclear antigen expression and the histological malignancy grade in mucoepidermoid carcinoma of salivary glands. RESULTS: there were 4 cases (36%) of low grade, 4 cases (36%) of intermediate grade and 3 cases (27%) of high grade of malignancy. After a comparative study between histological features and immunohistochemical analysis, significant differences were observed (P < 0.01) for low, intermediate and high grades: 16.04%, 26.98% and 56.98% of proliferating cell nuclear antigen expression in mucoepidermoid carcinoma , respectively. CONCLUSION: The proliferating cell nuclear antigen expression increases with the grade of malignancy in mucoepidermoid carcinoma of salivary glands.

Downloads

Download data is not yet available.

Author Biographies

Weder Pereira Cardoso, Heliópolis Hospital

MD. Department of Head and Neck Surgery of Heliópolis Hospital, São Paulo, Brazil.

Odilon Victor Porto Denardin, Heliópolis Hospital

MD, PhD. Department of Endocrinology of Heliópolis Hospital, São Paulo, Brazil.

Abrão Rapoport, Heliópolis Hospital

MD, PhD. Department of Head and Neck Surgery of Heliópolis Hospital, São Paulo, Brazil.

Vera Cavalcanti Araújo, Universidade de São Paulo

DDS, PhD. Pathology Department of the Dentistry Faculty, São Paulo University, São Paulo, Brazil.

Marcos Brasilino Carvalho, Heliópolis Hospital

MD, PhD. Department of Head and Neck Surgery of Heliópolis Hospital, São Paulo, Brazil.

References

Thackray AC, Lucas RB. Tumors of the major salivary glands. Atlas of Tumor Pathology, 2nd Series, Fascicle 10. Washington DC: Armed Forces Institute of Pathology; 1974.

Auclair PL, Ellis GL. Mucoepidermoid carcinoma. In: Ellis GL, Auclair PL, Gneep DR. Surgical pathology of salivary glands. Philadelphia: Saunders; 1991:269-98.

Franzi SA, Carvalho MB. Carcinoma mucoepidermóide avançado das glândulas salivares. Rev Bras Cancerol 1997;43(4):273-80.

Loyola AM, Araújo VC, Sousa SOM, Araújo NS. Minor salivary glands tumors. A retrospective study of 164 cases in a Brazilian population. Oral Oncol Eur J Cancer 1995;31B:197-201.

Seifert G, Sobin LH. World Health Organization histological classification of tumors. Histological typing of salivary gland tumors. Berlin: Springer; 1991:8-9.

Seifert G, Sobin LH. The World Health Organization Histological classification of salivary gland tumors: a commentary on the second edition. Cancer 1992;70:379-85.

Spiro RH, Huvos AG, Berk R, Strong EW. Mucoepidermoid carcinoma of salivary gland origin. Am J Surg 1978;136:461-8.

Rapoport A, Carvalho MB, Fava AS, et al. Diagnóstico e tratamento das neoplasias das glândulas salivares menores: estudo de 55 casos. Rev Col Bras Cirur 1988;5:289-93.

Ogawa I, Miyachi M, Takata T, Vuhahula E, Ijuhin N, Nikai H. Proliferative activity of salivary gland pleomorphic adenoma and myoepithelioma as evaluated by the proliferating cell nuclear antigen (PCNA) labeling index (LI). J Oral Pathol Med 1993;22:447-50.

Tsuji T, Sasaki K, Kimura Y, Yamada K, Mori M, Shinozaki F. Measurement of proliferating cell nuclear antigen (PCNA) and its clinical application in oral cancers. lnt J Oral Maxillofac Surg 1992;21:369-72.

Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978;121:2228-34.

Bravo R, Frank R, Blundell PA, MacDonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase d. Nature 1987;326:515-7.

McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992;21:591-4.

Garcia RL, Araújo VC, Araújo NS. Argyrophilia in nucleolar organizer regions (AgNOR) in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of the salivary glands. Eur Arch Otorhinolaryngol 1993;250:213-7.

Hall PA, Levinson DA, Woods AAL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin expression: an index of cell proliferation with evidence of deregulated expression in some neoplasms J Pathol 1990;162:285-94.

Kurki P, Vanderlaan M, Dolbear F, Gray J, Tam EM. Expression of proliferating cell nuclear (PCNA) cyclin during cell cycle. Exp Cell Res 1986;166:209-19.

Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands: evaluation and application of grading criteria in 143 cases. Cancer 1992;69:2021-30.

Eversole LR. Mucoepidermoid carcinoma: a review of 815 cases. J Oral Surg 1970;26:490-4.

Hicks MJ, El-Naggar AK, Flaitz CM, Luna MA, Batsakis JG. Histocytological grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: a clinicopathological and flow cytometric investigation. Head & Neck 1995;17:89-95.

Eveson JW, Cawson RA. Tumors of the minor (oropharyngeal) salivary glands: a demographic study of 336 cases. J Oral Pathol 1958;4:500-9.

Evans RW, Cruickshank AH. Mucoepidermoid tumors. In: Evans RW, Cruickshank AH. Epithelial tumors of the salivary glands. Philadelphia: W B Saunders; 1970:51-6.

Eversole LR, Rivin S, Sabes WR. Mucoepidermoid carcinoma of minor salivary glands: report of 17 cases with follow-up. J Oral Surg 1972;30:107-12.

Batsakis JG. Tumors of the Head and Neck. Baltimore: Williams & Wilkins; 1979:85-6.

Eneroth CM, Hjertman L, Moberger G. Mucoepidermoid carcinoma of the palate. Acta Otolaryng 1970;70:408-18.

Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands. Clinical and histopathological analysis of 234 cases with evaluation of grading criteria. Am Canc Soc 1998;82:1217-24.

Healey WV, Perzin KH, Smith L. Mucoepidermoid carcinoma of salivary gland origin. Classification clinical correlation and results of treatment. Cancer 1970;26:368-88.

Tsai ST, Jin YT. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinoma. J Oral Pathol Med 1995;24:313-5.

Downloads

Published

2000-05-05

How to Cite

1.
Cardoso WP, Denardin OVP, Rapoport A, Araújo VC, Carvalho MB. Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands. Sao Paulo Med J [Internet]. 2000 May 5 [cited 2025 Oct. 16];118(3):69-74. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2646

Issue

Section

Original Article